OVERVIEW

The market for closed system transfer devices is projected to hit USD 1.8 billion by 2026, rising at a CAGR of 19.4 percent during the forecast period, owing to the COVID-19 pandemic. Rising cancer prevalence, an increase in oncology drug approvals, increased usage of closed system transfer tools to combat the adverse effects of cytotoxic or antineoplastic drugs, and the creation of regulatory guidelines for safe handling and use of hazardous drugs are all driving growth in this market. COVID-19 will also be considered as a significant market contributor in the report.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Closed System Transfer Devices Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Closed System Transfer Devices Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Closed System Transfer Devices Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Closed System Transfer Devices Market

• • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Closed System Transfer Devices Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Closed System Transfer Devices Market ? By Closing Mechanism (Market Size ? &

• • 8.1 Push-to-turn Systems
  • 8.2 Color-to-color Alignment Systems
  • 8.3 Luer-lock Systems
  • 8.4 Click-to-lock Systems

• 9 Global Closed System Transfer Devices Market - By Type
  • 9.1 Membrane-to-membrane Systems
  • 9.2 Needleless Systems

• 10 Global Closed System Transfer Devices Market - By Component
  • 10.1 Vial Access Devices
  • 10.2 Syringe Safety Devices
  • 10.3 Bag/Line Access Devices
  • 10.4 Accessories

• 11 Global Closed System Transfer Devices Market - By Technology
  • 11.1 Diaphragm-based Devices
  • 11.2 Compartmentalized Devices
  • 11.3 Air Cleaning/Filtration Devices

• 12 Global Closed System Transfer Devices Market - By End-User
  • 12.1 Hospitals
  • 12.2 Oncology Centers & Clinics
  • 12.3 Other

• 13 Global Closed System Transfer Devices Market ? By Geography (Market Size ? &

• • 13.1 Introduction
  • 13.2 North America
    • 13.2.1 US
    • 13.2.2 Canada
    • 13.2.3 Mexico
  • 13.3 Europe
    • 13.3.1 U.K
    • 13.3.2 Germany
    • 13.3.3 Italy
    • 13.3.4 France
    • 13.3.5 Spain
    • 13.3.6 Rest of Europe
  • 13.4 Asia-Pacific
    • 13.4.1 China
    • 13.4.2 Japan
    • 13.4.3 India
    • 13.4.4 South Korea
    • 13.4.5 Rest of APAC
  • 13.5 Rest of the World
    • 13.5.1 South America
    • 13.5.2 Middle East
    • 13.5.3 Africa

• 14 Global Closed System Transfer Devices Market ? Entropy
  • 14.1 New product launches
  • 14.2 M&A's, collaborations, JVs and partnerships

• 15 Global Closed System Transfer Devices Market Company Profile (Key Players)
  • 15.1 Market Share, Company Revenue, Products, M&A, Developments
  • 15.2 Becton, Dickinson and Company (BD)
  • 15.3 ICU Medical, Inc.
  • 15.4 B. Braun Melsungen
  • 15.5 JMS Co., Ltd.
  • 15.6 Codan Medizinische Ger?te GmbH & Co Kg
  • 15.7 Victus, Inc.
  • 15.8 Equashield LLC.
  • 15.9 Teva Pharmaceutical Industries Ltd.
  • 15.10 Corvida Medical
  • 15.11 Yukon Medical
  • 15.12 Company 11 & more

• 16 Global Closed System Transfer Devices Market - Appendix
  • 16.1 Sources
  • 16.2 Abbreviations